Search results
PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed...
Benzinga via Yahoo Finance· 12 months agoPTC Therapeutics Inc (NASDAQ: PTCT) reported topline results from the MOVE-FA trial of vatiquinone...
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
Zacks via Yahoo Finance· 2 months agoPTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 12 months agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
Europe's CHMP Backs Approval Of PTC Therapeutics' Gene Therapy In Rare Neurometabolic Disorder
Benzinga via Yahoo Finance· 2 years agoThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has...
Raymond James Says PTC Therapeutics' CHMP Backing Is 'Under Exceptional Circumstances' What's Next
Benzinga via Yahoo Finance· 2 years agoLast week, PTC Therapeutics Inc's (NASDAQ: PTCT) Upstaza (PTC-AADC; AAV2-based DDC gene therapy)...
PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals — Here's Why
Investor's Business Daily· 12 months agoPTC stock plummeted Wednesday and gave its closest rival a boost after the company's treatment for a...
Promising gene therapy delivers treatment directly to brain
Associated Press via Yahoo News· 1 year agoWhen Rylae-Ann Poulin was a year old, she didn’t crawl or babble like other kids her age. A rare...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 week agoPTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC...
PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024
Zacks via Yahoo Finance· 7 months agoPTC Therapeutics (PTCT) will reduce its workforce in accordance with its strategic prioritization...
A Comprehensive Look at Sarepta's Growth and Innovation
GuruFocus.com via Yahoo Finance· 2 months agoSarepta Therapeutics, Inc. (NASDAQ:SRPT) is an American pharmaceutical company leading the global...